|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 12, 2018 ) The superdisintegrants market is expected to reach USD 536.5 million by 2023 from an estimated USD 366.4 million in 2018, at a CAGR of 7.9%.
Access Here for Free Sample Report at http://www.rnrmarketresearch.com/contacts/request-sample?rname=606051 .
182 Pages
10 Profiling
124 Tables
37 Figures
The increasing adoption of orally disintegrating tablets, growing generics market, and emergence of new superdisintegrants for the pharmaceutical industry are the factors driving the market for superdisintegrants.
Introduction
1 Objectives of the Study
2 Market Definition
3 Market Scope
4 Markets Covered
5 Years Considered for the Study
6 Currency
7 Stakeholders
8 Limitations
Premium Insights
1 Superdisintegrants Market Overview
2 Superdisintegrants Market: Geographic Growth Opportunities
3 Regional Mix: Superdisintegrants Market (2018–2023)
4 Synthetic Superdisintegrants Market, By Type and Region (2017)
5 Superdisintegrants Market: Developed vs Developing Markets, 2018 vs 2023
The prominent players in the global superdisintegrants market are Ashland Inc. (US), BASF SE (Germany), DowDuPont (US), JRS Pharma (Germany), DFE Pharma (Germany), Roquette (France), Asahi Kasei Corporation (Japan), Merck KGaA (Germany), Corel Pharma Chem (India), and Avantor Performance Materials, LLC (US).
Target Audience
1 Superdisintegrants Manufacturers
2 Superdisintegrants Distributors
3 Pharmaceutical and Biotechnology Companies
4 Research Institutes and Academic Centers
5 Contract Research Organizations (CROs)
6 Government Associations
7 Market Research and Consulting Firms
8 Venture Capitalists and Investors
Click Now for More Details on “Superdisintegrants Market by Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin), Formulation (Tablet, Capsules), Therapeutic Area (Gastrointestinal, Cardiovascular, Neurology, Oncology, Hematology) - Global Forecast to 2023” report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=606051 .
The shifting focus of pharmaceutical manufacturing to emerging markets and the growth of the overall pharmaceutical sector in these markets present significant opportunities for the superdisintegrants market growth. However, safety and quality concerns are expected to challenge the growth of the superdisintegrants market to a certain extent during the forecast period.
Break of primary participants was as mentioned below:
• By Company Type: Tier 1–48%, Tier 2–34% and Tier 3–18%
• By Designation: C-level–42%, Director Level–40%, Others–18%
• By Region: North America–38%, Europe–32%, Asia Pacific–21%, Latin America–6%, Middle East & Africa–3%
Buy this Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=606051 .
List of Tables
1 Increase in Geriatric Population Across the Globe
2 Drugs Facing Patent Expiry
3 Key Market Drivers: Impact Analysis
4 Key Market Opportunities: Impact Analysis
5 Key Market Challenges: Impact Analysis
6 Superdisintegrants Market, By Type, 2016–2023 (USD Million)
7 Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
8 Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
9 Synthetic Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
10 Crospovidone Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
ReportsnReports
Mr. Hrishikesh
+ 18883915441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
